SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-142317
Filing Date
2024-05-20
Accepted
2024-05-20 08:55:02
Documents
27
Period of Report
2024-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d768660d8k.htm   iXBRL 8-K 49706
2 EX-4.1 d768660dex41.htm EX-4.1 76256
3 EX-4.2 d768660dex42.htm EX-4.2 88658
4 EX-4.3 d768660dex43.htm EX-4.3 91593
5 EX-4.4 d768660dex44.htm EX-4.4 89819
6 EX-4.5 d768660dex45.htm EX-4.5 89857
7 EX-4.6 d768660dex46.htm EX-4.6 7909
8 EX-5.1 d768660dex51.htm EX-5.1 12592
9 EX-10.1 d768660dex101.htm EX-10.1 211819
10 EX-10.2 d768660dex102.htm EX-10.2 40444
11 EX-10.3 d768660dex103.htm EX-10.3 44512
12 EX-99.1 d768660dex991.htm EX-99.1 13049
16 GRAPHIC g768660g0520091203107.jpg GRAPHIC 3342
17 GRAPHIC g768660g0520091203364.jpg GRAPHIC 2500
18 GRAPHIC g768660snap1.jpg GRAPHIC 6413
  Complete submission text file 0001193125-24-142317.txt   1199704

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA ikt-20240520.xsd EX-101.SCH 2856
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikt-20240520_lab.xml EX-101.LAB 18737
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikt-20240520_pre.xml EX-101.PRE 11712
30 EXTRACTED XBRL INSTANCE DOCUMENT d768660d8k_htm.xml XML 3768
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39676 | Film No.: 24962582
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)